The final CY 2026 payment rates for brachytherapy sources are included in Addendum B to this final rule with comment period (which is available via the internet on the CMS website) and are identified with status indicator U. We continue to invite interested parties to submit recommendations for new codes to describe new brachytherapy sources
First 29 amino acids of growth hormone-releasing hormone (GHRH), which is 44 amino acids long
Disclaimer: This product is intended for research and laboratory use only
It contains methylcobalamin (vitamin B12), pyridoxine (vitamin B6), and nicotinamide, which help relieve symptoms such as numbness, tingling, weakness, fatigue, and nerve pain associated with vitamin B deficiency
Each provider has extensive hands-on experience in advanced injection techniques, body and facial aesthetics, and patient safety
FHIR APIs required by 2027